000 01236 a2200337 4500
005 20250512004417.0
264 0 _c19890825
008 198908s 0 0 eng d
022 _a0770-3198
024 7 _a10.1007/BF02214106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDvornik, D
245 0 0 _aTheoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins.
_h[electronic resource]
260 _bClinical rheumatology
_cMar 1989
300 _a16-24 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _a6-Ketoprostaglandin F1 alpha
_xbiosynthesis
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aDinoprostone
_xbiosynthesis
650 0 4 _aEtodolac
650 0 4 _aGastric Mucosa
_xdrug effects
650 0 4 _aGastritis
_xchemically induced
650 0 4 _aIndoleacetic Acids
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
700 1 _aLee, D K
773 0 _tClinical rheumatology
_gvol. 8 Suppl 1
_gp. 16-24
856 4 0 _uhttps://doi.org/10.1007/BF02214106
_zAvailable from publisher's website
999 _c2531947
_d2531947